New breakthrough brings Muscular Dystrophy Defect drug closer to reality

Researchers have revealed an atomic-level view of a genetic defect that causes a form of muscular dystrophy, myotonic dystrophy type 2.

By: Agencies | | Published: January 6, 2014 12:38 pm

Researchers have revealed an atomic-level view of a genetic defect that causes a form of muscular dystrophy, myotonic dystrophy type 2. Also Read - 7 reasons why the #BeefBan is good

The scientists from The Scripps Research Institute have used this information to design drug candidates with potential to counter those defects and reverse the disease. Also Read - Are you suffering from muscular dystrophy? Go au naturel to deal with it

‘This the first time the structure of the RNA defect that causes this disease has been determined,’ lead author Matthew Disney said. ‘Based on these results, we designed compounds that, even in small amounts, significantly improve disease-associated defects in treated cells.’ Also Read - Gene editing on dogs shows promise in treating muscular dystrophy

Myotonic dystrophy type 2 is a relatively rare form of muscular dystrophy that is somewhat milder than myotonic dystrophy type 1, the most common adult-onset form of the disease.

Both types of myotonic dystrophy are inherited disorders that involve progressive muscle wasting and weakness, and both are caused by a type of genetic defect known as a ‘RNA repeat expansion,’ a series of nucleotides repeated more times than normal in an individual’s genetic code.

The repeat binds to the protein MBNL1, rendering it inactive and resulting in RNA splicing abnormalities—which lead to the disease.

Using information about the RNA’s structure and movement, the scientists were able to design molecules to improve RNA function.

The new findings were confirmed using sophisticated computational models that show precisely how the small molecules interact with and alter the RNA structure over time.

Those predictive models matched what the scientists found in the study—that these new compounds bind to the repeat structure in a predictable and easily reproducible way, attacking the cause of the disease.

Source: ANI

For more articles, visit our Diseases and Conditions Section and for videos check out our YouTube Channel. Don’t miss out on the latest updates. Follow us on Facebook, Twitter and Google Plus.

Published : January 6, 2014 12:38 pm

Read Disclaimer

Cancer - your most common queries answered by an expert

Is Gujarat really shining? Fall in Maternal mortality rate lower than national average!

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Cancer - your most common queries answered by an expert

Is Gujarat really shining? Fall in Maternal mortality rate lower than national average!

7 reasons why the #BeefBan is good

Are you suffering from muscular dystrophy? Go au naturel to deal with it

Gene editing on dogs shows promise in treating muscular dystrophy

A new hope for muscular dystrophy patients

Weight loss diet: How to eat healthy in a restaurant when you want to lose weight

About The health Site

Useful Links